Biomedical Engineering Reference
In-Depth Information
70. Toub, N.; Malvy, C.; Fattal, E. Innovative Nanotechnologies for the Delivery of Oligonucle-
otides and siRNA.
Biomed. Pharmacother.
2006,
60,
607-620.
71. Pille, J. Y.; Li, H.; Blot, E.; Bertrand, J. R.; Pritchard, L. L.; Opolon, P.; Maksimenko, A.; Lu, H.;
Vannier, J. P.; Soria, J.; Malvy, C.; Soria, C. Intravenous Delivery of Anti-RhoA Small Inter-
fering NA Loaded in Nanoparticles of Chitosan in Mice: Safety and Efficacy in Xenografted
Aggressive Breast Cancer.
Hum. Gene. Ther.
2006,
17,
1019-1026.
72. Urban-Klein, B.; Werth, S.; Abuharbeid, S.; Czubayko, F.; Aigner, A. RNAi-mediated Gene-
targeting Through Systemic Application Of Polyethylenimine (PEI)-complexed siRNA In
vivo.
Gene Ther.
2005,
12,
461-466.
73. Kong, X.; Hellermann, G. R.; Zhang, W.; Jenna, P.; Kumar, M. N.; Behera, A.; Behera, S.;
Lockeey, R.; Mohapatra, S. S. Chitosan Interferon-γ Nanogene Therapy for Lung Disease:
Modulation of T-Cell and Dendritic Cell Immune Responses.
Allergy Asthma Clin. Immunol.
2008,
4,
95-105.
74. Park, T. G.; Jeong, J. H.; Kim, S. W. Current Status of Polymeric Gene Delivery Systems.
Adv.
Drug Deliv. Rev.
2006,
58,
467-486.
75. SHi, X.; Wang, S. X.; Meshinchi, S.; Van Antwerp, M. E.; Bi, X.; Lee, I.; Baker, J. R. J.
Dendrimer-entrapped Gold Nanoparticles as a Platform for Cancer-Cell Targeting and Imag-
ing.
Small
2007,
3,
1245-1252.
76. Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K. R.; Han, M. S.; Mirkin, C. A.
Oligonucleotidemodified Gold Nanoparticles for Infracellular Gene Regulation.
Science
2006,
312,
1020-1027.
77. Sullivan, M. M. O.; Green, J. J.; Przybycien, T. M. Development of a Novel Gene Delivery
Scaffold Utilizing Colloidal Gold-polyethylenimine Conjugates for DNA Condensation.
Gene
Ther.
2003,
22,
1882-1890.
78. Mirkin, C. A.; Letsinger, R. L.; Mucic, R. C.; Storhoff, J. J. A DNA-based Method for
Rationally Assembling Nanoparticles into Macroscopic Materials.
Nature
1996,
382,
607-609.
79. Paciotti, G. F.; Myer; Weinreich, D.; Goia; Pavel; McLaughlin, E.; Tamarkin, L. Colloidal
Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery.
Drug Deliv
.
2004,
11
,
169−183
80. Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, M. D. Gold Nanoparticles are
Taken Up by Human Cells But Do Not Cause Acute Cytotoxicity.
Small
2005,
1,
325.
81. Andrews, P. R.; Craik, D. J.; Martin, J. L. Functional Group Contributions to Drug-Receptor
Interactions.
J. Med. Chem.
1984,
27,
1648-1657.
82. Jin, R.; Wu, G.; Li, Z.; Mirkin, C. A.; Schatz, G. C. What Controls the Melting Properties of
DNA-linked Gold Nanoparticle Assemblies?
JACS
2003,
125,
1643-1654.
83. Akamatsu, K.; Kimura, M.; Shibata, Y.; Nakano, S.; Miyoshi, D.; Nawafune, H.; Sugimoto, N.
A DNA Duplex with Extremely Enhanced Thermal Stability Based on Controlled Immobili-
zation on Gold Nanoparticles.
Nano Lett.
2006,
6,
491-495.
84. Prabha, S.; Labhasetwar, V. Nanoparticle-mediated Wild-type p53 Gene Delivery Results in
Sustained Antiproliferative Activity in Breast Cancer Cells.
Mol. Pharm.
2004,
1
.
85. Li, S.; Huang, L. Nonviral Gene Therapy: Promises and Challenges.
Gene Ther.
2000,
7,
31-34.
86. Brown, M. D.; Schatzlein, A. G.; Uchegbu, I. F. Gene Delivery with Synthetic (Non Viral)
Carriers.
Int. J. Pharm.
2000,
229,
1-21.
87. Bonadio, J.; Smiley, E.; Patil, P.; Goldstein, S. Localized, Direct Plasmid Gene Delivery In
vivo: Prolonged Therapy Results in Reproducible Tissue Regeneration.
Nat Med.
1999,
5,
753-759.
